Mereo BioPharma Balance Sheet (2020-2025) | MREO

Balance Sheet Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Accumulated Depreciation 0.74M0.80M0.84M0.88M0.96M0.95M1.02M1.11M1.05M
Assets
Current Assets
Cash & Equivalents 20.30M30.99M32.80M127.11M118.75M68.18M57.42M48.70M87.43M80.52M69.80M62.50M56.12M48.70M
Receivables - Other 2.28M1.34M1.44M1.91M1.27M1.95M
Prepaid Assets 1.74M2.14M6.18M3.77M3.45M5.45M5.16M3.19M4.49M3.83M2.17M2.52M2.54M2.69M
Current Assets 82.80M39.25M168.20M133.89M103.02M75.20M63.76M53.50M93.94M86.72M74.76M66.90M61.42M52.41M
Non-Current Assets
Property, Plant & Equipment (Net) 13.94M2.08M3.34M3.41M2.66M0.55M0.41M0.36M0.34M0.32M0.26M0.25M0.22M0.17M
Intangibles 39.58M43.58M31.02M33.11M30.37M1.09M0.97M0.87M0.80M0.64M0.55M0.47M0.64M
Goodwill & Intangibles 39.58M43.58M31.02M33.11M30.37M1.09M0.97M0.87M0.80M0.64M0.55M0.47M0.64M
Other Non-Current Assets 0.61M0.47M0.44M0.38M0.38M0.40M0.39M
Non-Current Assets 53.52M43.87M34.36M36.52M33.03M2.22M2.74M2.44M2.19M2.02M1.63M1.42M1.21M1.20M
Assets 136.32M83.12M202.55M170.41M136.05M77.41M66.50M55.94M96.13M88.75M76.39M68.32M62.63M53.60M
Liabilities
Current Liabilities
Accounts Payables 6.82M4.40M3.06M3.37M3.55M3.49M2.35M2.46M2.70M1.75M2.44M2.92M1.14M0.88M
Notes Payables 13.33M4.63M4.93M5.55M5.54M
Payables 6.82M4.40M3.06M3.37M3.55M16.82M2.35M7.08M7.63M7.30M7.97M2.92M1.14M0.88M
Accumulated Expenses 3.35M5.52M5.88M5.16M6.41M5.44M5.47M2.54M3.72M3.53M4.07M2.93M5.04M4.12M
Other Accumulated Expenses 1.07M1.02M0.72M3.44M2.64M1.09M0.89M0.78M0.62M
Short term Debt 0.49M
Current Leases 13.87M1.53M2.73M2.36M1.83M0.56M0.65M0.66M0.68M0.74M0.71M0.75M0.60M0.40M
Current Taxes 1.84M3.73M1.65M2.05M-1.93M
Total Current Liabilities 27.69M11.31M13.80M16.91M44.34M9.49M11.00M15.47M14.21M13.85M7.50M7.56M6.02M
Non-Current Liabilities
Non-Current Debt 18.01M21.31M25.07M19.39M20.09M
Convertible Debt 4.39M
Operating Leases 1.53M2.36M1.48M0.91M1.39M0.55M0.39M0.19M
Other Non-Current Liabilities 44.40M67.05M47.54M11.24M8.69M0.87M0.76M0.85M0.93M1.04M0.82M0.42M0.55M0.65M
Total Non-Current Liabilities 78.44M91.58M75.99M34.88M4.09M25.14M15.20M12.24M16.55M15.17M14.60M7.82M7.91M6.35M
Total Liabilities 106.21M102.89M89.78M51.78M48.42M26.01M15.96M13.10M17.48M16.21M15.42M8.24M8.45M7.00M
Shareholder's Equity
Total Debt 18.01M21.31M25.07M19.39M20.09M0.49M
Common Equity 30.10M-19.77M112.77M118.63M87.63M51.40M50.54M42.84M78.65M72.54M60.97M60.08M54.18M46.60M
Shareholder's Equity 118.63M87.63M51.40M50.54M42.84M78.65M72.54M60.97M60.08M54.18M46.60M
Liabilities and Shareholders Equity 136.32M83.12M202.55M170.41M136.05M77.41M66.50M55.94M96.13M88.75M76.39M68.32M62.63M53.60M
Treasury Shares 0.92M1.34M0.86M0.86M0.86M0.98M0.98M0.98M
Retained Earnings -336.10M-408.93M-415.97M-400.32M-398.10M-404.57M-419.63M-428.60M-440.84M-455.84M-462.88M-472.03M-486.64M-493.70M
Shares Outstanding 788.46M624.93M701.22M701.22M701.35M768.82M773.67M775.73M795.00M795.00M795.48M